405 results on '"Jiménez-Fonseca, Paula"'
Search Results
2. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
3. Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer
4. Catheter – related thrombosis in cancer patients: Data from the registry of thrombosis and nEoplasia of SEOM (TESEO)
5. CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer
6. Using the emotional functioning in clinical practice to detect psychological distress in patients with advanced thoracic and colorectal cancer
7. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
8. State of the scientific evidence and recommendations for the management of older patients with gastric cancer
9. MALESTAR PSICOLÓGICO EN PACIENTES CON CÁNCER AVANZADO DURANTE LA PANDEMIA DE COVID-19
10. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
11. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
12. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
13. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study
14. The Mediating Role of Exercise in Depression and Fatigue in Patients with Advanced Cancer
15. Psychometric properties of the Spanish version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
16. Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis
17. Measurement properties of the Spanish version of the brief resilient coping scale (BRCS) in cancer patients
18. The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms
19. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence
20. Anxiety and depression in patients with advanced cancer during the COVID-19 pandemic
21. Dignity and psychosocial related variables in elderly advanced cancer patients
22. Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality
23. Learning in times of stress: Lessons from COVID-19 that will last throughout this century
24. Fear of Recurrence in Advanced Cancer Patients: Sociodemographic, Clinical, and Psychological Correlates
25. Psychometric properties of Spanish version of the Mini-Mental Adjustment to Cancer Scale
26. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus
27. Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival
28. Impact of the COVID-19 pandemic on care and psychological impact on cancer patients
29. Psychometric Properties of the PDRQ-9 in Cancer Patients: Patient-Doctor Relationship Questionnaire /Propiedades Psicometricas del PDRQ-9 en Pacientes con Cancer: Cuestionario de Relacion Medico-Paciente
30. A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry
31. Factor structure and measurement invariance of the Brief Symptom Inventory (BSI-18) in cancer patients
32. Nab -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer
33. Psychometric properties and factorial analysis of invariance of the Satisfaction with Life Scale (SWLS) in cancer patients
34. Quality of life, coping, and psychological and physical symptoms after surgery for non-metastatic digestive tract cancer
35. Breathlessness in Advanced Cancer Patients: Protocols and Recommendations
36. Effects of pessimism, depression, fatigue, and pain on functional health-related quality of life in patients with resected non-advanced breast cancer
37. Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors
38. Coping strategies as mediators of uncertainty and psychological distress in patients with advanced cancer
39. Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment
40. Psychometric properties of the Shared Decision-Making Questionnaire (SDM-Q-9) in oncology practice
41. Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis
42. Nutritional support and parenteral nutrition in cancer patients: An expert consensus report
43. Soporte nutricional y nutrición parenteral en el paciente oncológico: informe de consenso de un grupo de expertos
44. Quality of Life and Psychological Distress in Advanced Cancer Patients: Associations with Sociodemographic and Clinical Factors
45. Management of infection and febrile neutropenia in patients with solid cancer
46. Manejo de la infección y la neutropenia febril en el paciente con cáncer sólido
47. Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival.
48. The Relationship between Therapeutic Alliance and Quality of Care in Patients with Advanced Cancer in Spain
49. Mental Adjustment, Functional Status, and Depression in Advanced Cancer Patients
50. Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.